Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GBT - Pfizer inks $5.4B deal to acquire SCD drug maker Global Blood Therapeutics - WSJ

GBT - Pfizer inks $5.4B deal to acquire SCD drug maker Global Blood Therapeutics - WSJ

Global Blood Therapeutics Inc.

  • Pfizer ( NYSE: PFE ) has agreed to buy Global Blood Therapeutics ( GBT ) for $5.4B in cash, The Wall Street Journal reported on Monday citing people familiar with matter ahead of a formal announcement from the companies.
  • According to the people, Pfizer is expected to pay $68.50 per share in cash for Global Blood ( GBT ) which markets sickle cell disease therapy Oxbryta tablets.
  • Last Friday, The Journal reported that the companies were in advanced talks to form a deal sending Global Blood ( GBT ) shares to close ~33% higher.

For further details see:

Pfizer inks $5.4B deal to acquire SCD drug maker Global Blood Therapeutics – WSJ
Stock Information
Company Name: Global Blood Therapeutics Inc.
Stock Symbol: GBT
Market: NASDAQ
Website: gbt.com
Menu
GBT GBT Quote GBT Short GBT News GBT Articles GBT Message Board
Get GBT Alerts

News, Short Squeeze, Breakout and More Instantly...